Altered Tissue Distribution and Elimination of Amikacin Encapsulated in Unilamellar, Low-Clearance Liposomes (MiKasome®) - Fielding, Robert M.; Lewis, Ramilla O.; Moon-McDermott, Lotus (Pharmaceutical research, 1998)
Keywords: Amikacin - administration & dosage; Amikacin - blood; Amikacin - pharmacokinetics; Animals; Antibacterial agents; Antibiotics. Antiinfectious agents. Antiparasitic agents; Biological and medical sciences; Drug Carriers; General pharmacology; Liposomes; Male; Medical sciences; Metabolic Clearance Rate; Pharmaceutical technology. Pharmaceutical industry; Pharmacology. Drug treatments; Rats; Rats, Sprague-Dawley; Tissue Distribution; Urine; Pharmaceutical technology; Intravenous administration; Amikacin; Rat; Rodentia; Elimination; Liposome; Blood plasma; Vertebrata; Antibiotic; Mammalia; Aminoglycoside; Animal; Distribution; Dosage form; Antibacterial agent; Pharmacokinetics